Predictors and outcomes associated with hydroxyurea sensitivity in acute myeloid leukemia patients with high hyperleukocytosis

Leuk Lymphoma. 2020 Mar;61(3):737-740. doi: 10.1080/10428194.2019.1683735. Epub 2019 Nov 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Hydroxyurea* / adverse effects
  • Leukemia, Myeloid, Acute* / complications
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukocytosis / chemically induced

Substances

  • Hydroxyurea